HOPKINTON, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. , a leading provider of life sciences tools, today announced the availability of two new products that expand the LabChip GX product line: a GLP/GMP-compliant version of the operating software for the LabChip GX instrument that is amenable to manufacturing QC environments and a new protein assay with higher, silver stain levels of sensitivity. The LabChip GX platform has been broadly adopted by biopharmaceutical companies and academic institutions for protein therapeutics, vaccines, and nucleic acid applications.
“The LabChip GXII is an integral part of our analytical platform that allows us to quickly screen thousands of our protein expression strains for producing vaccines and protein drug candidates in a variety of therapeutic areas,” said Jeffrey Allen, Director of Analytical Biochemistry at Pfenex. “Whether as a standalone unit or more recently integrated with our Caliper Sciclone((R)) liquid handler and other robotic instruments, the GXII not only improves our throughput, but also helps us automate our research processes more than ever before.”
Caliper’s substantial collection of patented tools and approaches, including microfluidic chips, instrument design, software data displays and analysis are changing the way research is performed in laboratories around the globe, and Caliper continues to strengthen its intellectual property in this key product area.
LabChip, Sciclone, EZ Reader, and Staccato are registered trademarks of Caliper Life Sciences, Inc.
CONTACT: Melissa Bruno or Kristin Villiotte, both of Schwartz
Communications, +1-781-684-0770, caliper@schwartz-pr.com, for Caliper Life
Sciences, Inc.
Web site: http://www.caliperls.com/
